Register
Medicines reference
Product

Sex Barrier Female

Water-soluble mepregenol acetate + Ethinylestradiol · NPK SKiFF / Astrafarm

1 form: tablet. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
Tablet · Cat up to 5 kg Cat up to 5 kg Estrus Interruption · By mouth: 1 tabletEstrus Prevention · By mouth: -Post-mating Contraception · By mouth: - - Georgia Yes, veterinary
In force until 01 Feb 2029
Veterinary (National Food Agency)
In the register: სექს ბარიერი®
№ 000547 | 000548
Verified on: 21 Oct 2026
Tablet · Cat Any weight Cat Any weight Estrus Interruption · By mouth: -Estrus Prevention · By mouth: 1 tabletPost-mating Contraception · By mouth: 2 tablets - Georgia Yes, veterinary
In force until 01 Feb 2029
Veterinary (National Food Agency)
In the register: სექს ბარიერი®
№ 000547 | 000548
Verified on: 21 Oct 2026
Tablet · Cat 5–10 kg Cat 5–10 kg Estrus Interruption · By mouth: 1–2 tabletsEstrus Prevention · By mouth: -Post-mating Contraception · By mouth: - - Georgia Yes, veterinary
In force until 01 Feb 2029
Veterinary (National Food Agency)
In the register: სექს ბარიერი®
№ 000547 | 000548
Verified on: 21 Oct 2026
Tablet · Dog up to 5 kg Dog up to 5 kg Estrus Prevention · By mouth: 1 tabletEstrus Interruption · By mouth: 1 tabletPost-mating Contraception · By mouth: 1 tablet - Georgia Yes, veterinary
In force until 01 Feb 2029
Veterinary (National Food Agency)
In the register: სექს ბარიერი®
№ 000547 | 000548
Verified on: 21 Oct 2026
Tablet · Dog 5–10 kg Dog 5–10 kg Estrus Prevention · By mouth: 1–2 tabletsEstrus Interruption · By mouth: 1–2 tabletsPost-mating Contraception · By mouth: 1–2 tablets - Georgia Yes, veterinary
In force until 01 Feb 2029
Veterinary (National Food Agency)
In the register: სექს ბარიერი®
№ 000547 | 000548
Verified on: 21 Oct 2026
Tablet · Dog 10–30 kg Dog 10–30 kg Estrus Prevention · By mouth: 2–4 tabletsEstrus Interruption · By mouth: 2–4 tabletsPost-mating Contraception · By mouth: 2–4 tablets - Georgia Yes, veterinary
In force until 01 Feb 2029
Veterinary (National Food Agency)
In the register: სექს ბარიერი®
№ 000547 | 000548
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Sex Barrier Female, Tablet

Sex Barrier 0.1/0.001 mg tablets, N10 for female cats and dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full female label: oestrus postponement, oestrus interruption and post-mating use in bitches with mepregenol acetate 0.1 mg plus ethinylestradiol 0.001 mg tablets dosed by weight band
3.7/10
Poor / unconvincing
vetman assessment

Sex Barrier Female

Sex Barrier 0.1/0.001 mg tablets, N10 for female cats and dogs
Assessed clinical scopeDog · Full female label: oestrus postponement, oestrus interruption and post-mating use in bitches with mepregenol acetate 0.1 mg plus ethinylestradiol 0.001 mg tablets dosed by weight band · By mouth
Care settingVeterinary prescription for a healthy, sexually mature bitch after excluding pregnancy, reproductive and mammary disease, diabetes and urolithiasis, with follow-up after the course
vetman score 3.7/10 Poor / unconvincing
Evidence confidence: Low Georgia: Yes, veterinary · № 000547 | 000548 · Verified on 21 Oct 2026

A poor choice: an unproven hormone combination whose post-mating oestrogen use carries pyometra risk. Prefer surgical neutering; after mismating, aglepristone, authorised in many European countries, is the evidence-based option.

Regulatory and scientific credibility3.5/10

The female formulation is registered in Georgia (000547/000548, valid to 2029) with a 2023 Russian-language instruction, but mepregenol acetate has no EU, UK or US veterinary authorisation documented in the reviewed evidence and no public dossier exists.

Clinical efficacy3.5/10

Only manufacturer material supports this combination; there are no independent studies of oestrus postponement or of pregnancy prevention after mating in bitches.

Safety and tolerability3.0/10

Progestogens in bitches cause cystic endometrial hyperplasia, pyometra and mammary nodules, and oestrogen given after mating adds pyometra risk; the label excludes greyhounds and limits interruption to once and postponement to twice a year.

Clinical practicality5.5/10

Weight-banded tablet counts work up to 30 kg, but above 30 kg the dose follows a stepped rule, postponement must start 7-14 days before the expected oestrus, and the male and female formulations are easy to mix up.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in greyhounds, in pregnancy or lactation, before sexual maturity, or with mammary or genital tumours, reproductive disease, diabetes or urolithiasis.
  • Oestrogen after mating raises pyometra risk: check for vaginal discharge, thirst, lethargy or fever in the weeks after a course.
  • Interrupt oestrus no more than once a year and postpone it no more than twice a year.
  • Female formulation only; above 30 kg give 4 tablets plus 1 for each further 10 kg, as the label states.
  • Full reproductive function returns about 2-3 months after stopping.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full female label: oestrus prevention, oestrus interruption and post-mating use in queens with mepregenol acetate 0.1 mg plus ethinylestradiol 0.001 mg tablets
3.8/10
Poor / unconvincing
vetman assessment

Sex Barrier Female

Sex Barrier 0.1/0.001 mg tablets, N10 for female cats and dogs
Assessed clinical scopeCat · Full female label: oestrus prevention, oestrus interruption and post-mating use in queens with mepregenol acetate 0.1 mg plus ethinylestradiol 0.001 mg tablets · By mouth
Care settingVeterinary prescription for a healthy, sexually mature queen after excluding pregnancy, reproductive and mammary disease, diabetes and urolithiasis
vetman score 3.8/10 Poor / unconvincing
Evidence confidence: Low Georgia: Yes, veterinary · № 000547 | 000548 · Verified on 21 Oct 2026

A poor choice: an unproven progestogen and oestrogen combination with the full hormonal risk profile in cats. Surgical neutering is the standard; if short hormonal control is unavoidable, use a better documented product under veterinary supervision.

Regulatory and scientific credibility3.5/10

The female formulation is registered in Georgia (000547/000548, valid to 2029) with a 2023 Russian-language instruction, but mepregenol acetate has no EU, UK or US veterinary authorisation documented in the reviewed evidence and no public dossier exists.

Clinical efficacy3.5/10

Only manufacturer material supports this progestogen and oestrogen combination; there are no independent studies of oestrus control or of pregnancy prevention after mating.

Safety and tolerability3.0/10

Progestogens in cats are linked to diabetes, mammary hyperplasia and tumours, and pyometra, and an added oestrogen increases uterine risk; the label itself excludes diabetes, urolithiasis and reproductive or mammary disease.

Clinical practicality6.0/10

One tablet per cat every 14 days, or daily for 3-5 days, is easy to give, but the separate male and female formulations are easy to mix up.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in pregnancy or lactation, before sexual maturity, or with mammary or genital tumours, reproductive disease, diabetes or urolithiasis.
  • Female formulation only: never give the male tablets (0.4 mg/0.02 mg) to a queen.
  • Check glucose and the mammary glands on long courses, and watch for vaginal discharge or illness after treatment, which can signal pyometra.
  • Post-mating use (2 tablets within 24 hours) has no independent evidence of preventing pregnancy; confirm pregnancy status later.
  • Full reproductive function returns about 2-3 months after stopping.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Water-soluble mepregenol acetate0.1 mg/tablet Ethinylestradiol0.001 mg/tablet
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Registration
Georgia Yes, veterinary
In force until 01 Feb 2029
Veterinary (National Food Agency)
In the register: სექს ბარიერი®
№ 000547 | 000548
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
Cat
WeightEstrus Interruption · By mouthEstrus Prevention · By mouthPost-mating Contraception · By mouth
up to 5 kg 1 tablet - -
Any weight - 1 tablet 2 tablets
5–10 kg 1–2 tablets - -
  • Estrus Interruption · By mouth (once daily for 3-5 days; start no later than day 2 of estrus): Female formulation only. Do not use in pregnancy, lactation, before sexual maturity, mammary/genital neoplasia, reproductive disease, diabetes, urolithiasis or ingredient intolerance. Do not use the male formulation.
  • Estrus Prevention · By mouth (every 14 days during sexual rest; may continue without breaks): Female cats only. Observe all female-formulation contraindications. Full reproductive function returns 2-3 months after stopping.
  • Post-mating Contraception · By mouth (single dose no later than 24 hours after accidental mating): Female cats only. Observe all female-formulation contraindications. Full reproductive function returns 2-3 months after stopping.
Source:
Sex Barrier female label
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Sex Barrier tablets for female cats and dogs - approved instruction
Rosselkhoznadzor-approved veterinary instruction, 2023
Dog
WeightEstrus Prevention · By mouthEstrus Interruption · By mouthPost-mating Contraception · By mouth
up to 5 kg 1 tablet 1 tablet 1 tablet
5–10 kg 1–2 tablets 1–2 tablets 1–2 tablets
10–30 kg 2–4 tablets 2–4 tablets 2–4 tablets
  • Estrus Prevention · By mouth (once daily for 5-7 days; start 7-14 days before expected estrus): Female dogs only. Do not use in greyhounds, pregnancy, lactation, before sexual maturity, mammary/genital neoplasia, reproductive disease, diabetes, urolithiasis or ingredient intolerance. Estrus interruption is recommended no more than once yearly; estrus delay no more than twice yearly.
  • Estrus Interruption · By mouth (once daily for 3-5 days; start no later than day 2 of estrus): Female dogs only. Do not use in greyhounds, pregnancy, lactation, before sexual maturity, mammary/genital neoplasia, reproductive disease, diabetes, urolithiasis or ingredient intolerance. Estrus interruption is recommended no more than once yearly; estrus delay no more than twice yearly.
  • Post-mating Contraception · By mouth (once daily for 2 days; start no later than 24 hours after accidental mating): Female dogs only. Do not use in greyhounds, pregnancy, lactation, before sexual maturity, mammary/genital neoplasia, reproductive disease, diabetes, urolithiasis or ingredient intolerance. Estrus interruption is recommended no more than once yearly; estrus delay no more than twice yearly.
Source:
Sex Barrier female label
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Sex Barrier tablets for female cats and dogs - approved instruction
Rosselkhoznadzor-approved veterinary instruction, 2023

Water-soluble mepregenol acetate: No dose supported by a publicly verifiable source yet

Ethinylestradiol: No dose supported by a publicly verifiable source yet

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.